Physician profile
Heath E Saltzman
NPI 1982813887
$15,094.01
in general payments reported to CMS, 2019-2025
25 companies · $2,070 in 2025
The $2,070 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,034 · 2020: $627 · 2021: $1,591 · 2022: $2,336 · 2023: $2,036 · 2024: $2,400 · 2025: $2,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,784 · Travel and Lodging: $1,721 · Education: $0.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,783.89 |
| Travel and Lodging | $1,721.05 |
| Education | $0.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,832.88 | 2019-2025 | Watchman Flx, Farapulse, General - Therapies |
| Abbott Laboratories | $3,034.47 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Medtronic, INC. | $1,831.55 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,718.50 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $1,468.27 | 2019-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $1,073.78 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $816.76 | 2019 | |
| Atricure, INC. | $269.73 | 2019-2024 | |
| Cardiva Medical, INC. | $204.73 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $166.16 | 2019-2020 | |
| Edwards Lifesciences Corporation | $161.68 | 2019 | |
| Pfizer INC. | $86.98 | 2020-2025 | |
| Amgen INC. | $72.43 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $61.62 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $54.91 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $50.87 | 2023 | |
| Novartis Pharmaceuticals Corporation | $46.70 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $29.64 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.47 | 2019-2025 | Camzyos |
| Bardy Diagnostics, INC. | $20.00 | 2020 | |
| Ionis Pharmaceuticals, INC. | $18.49 | 2025 | Tryngolza |
| Kestra Medical Technology Services, INC. | $17.00 | 2024 | Assure Wcd |
| Irhythm Technologies, INC. | $14.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heath Saltzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.